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Abstract: Prenatal tobacco exposure is a significant, preventable cause of childhood morbidity,
yet little is known about exposure risks for many race/ethnic subpopulations. We studied
active smoking and environmental tobacco smoke (ETS) exposure in a population-based cohort
of 13 racially/ethnically diverse pregnant women: white, African American, Hispanic, Native
American, including nine Asian/Pacific Islander subgroups: Chinese, Japanese, Korean, Filipino,
Cambodian, Vietnamese, Laotian, Samoan, and Asian Indians (N = 3329). Using the major nicotine
metabolite, cotinine, as an objective biomarker, we analyzed mid-pregnancy serum from prenatal
screening banked in 1999–2002 from Southern California in an effort to understand differences in
tobacco exposure patterns by race/ethnicity, as well as provide a baseline for future work to assess
secular changes and longer-term health outcomes. Prevalence of active smoking (based on age- and
race-specific cotinine cutpoints) was highest among African American, Samoan, Native Americans
and whites (6.8–14.1%); and lowest among Filipinos, Chinese, Vietnamese and Asian Indians
(0.3–1.0%). ETS exposure among non-smokers was highest among African Americans and Samoans,
followed by Cambodians, Native Americans, Vietnamese and Koreans, and lowest among Filipinos,
Japanese, whites, and Chinese. At least 75% of women had detectable cotinine. While for most
groups, levels of active smoking corresponded with levels of ETS, divergent patterns were also found.
For example, smoking prevalence among white women was among the highest, but the group’s ETS
exposure was low among non-smokers; while Vietnamese women were unlikely to be active smokers,
they experienced relatively high ETS exposure. Knowledge of race/ethnic differences may be useful
in assessing disparities in health outcomes and creating successful tobacco interventions.
Keywords: tobacco; smoking; cotinine; prenatal; environmental tobacco smoke; passive smoking;
Native American; Asian; race; ethnicity
1. Introduction
Tobacco exposure remains the leading preventable cause of death and disease in the U.S. [1].
Prenatal tobacco exposure, through active smoking or environmental tobacco smoke (ETS), is one of
the most significant avoidable causes of maternal and child morbidity and mortality [1,2]. Deleterious
effects include pre-term birth, fetal growth restriction, low birth weight, miscarriage, specific congenital
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malformations, childhood leukemia, reduced maternal fertility, adverse respiratory, neurological and
cardiovascular effects, and infant death [2–10]. Compared to active smoking, the effects of ETS are
similar and consistent though attenuated [11–14]. The effects of prenatal exposure may manifest
in childhood, with increased risk of impaired lung function, asthma, obesity, cognitive deficits and
detrimental cardiovascular consequences [15–23]. Epigenetic changes from in-utero exposure to
tobacco have been detected in children [24], and prenatal smoking has been shown to influence
smoking habits of future generations [25,26].
Despite over 50 years of tobacco control policies that have reduced overall self-reported smoking
prevalence in the U.S., smoking prevalence during pregnancy in the U.S. declined only slightly in
the decade between 2000 to 2010 from 13.3% in 2000 to 12.3%, making the U.S. Healthy People 2020
goal of 1.4% unlikely in the near future [3]. Furthermore, the true smoking prevalence is likely higher;
a validation study that measured serum cotinine, a biomarker for nicotine, estimated that 23% of
pregnant and 9% of non-pregnant female smokers did not disclose their smoking [27]. Data on exposure
to ETS is not routinely collected, and self-report is poorly correlated with objective biomarkers [28,29].
Without consistent, sensitive and objective measures, it is unclear what the true exposure
differences between race/ethnic subgroups of pregnant women are [1,3,30], which is critical in designing
effective, targeted intervention strategies and ultimately reducing disparities. National surveillance
data based on self-report showed variability in prenatal smoke exposure patterns between different
race/ethnic groups, with the highest rates of prenatal smoking in American Indian/Alaskan Native
women, followed by white and African American women, and lower rates in Hispanics and Asians [31].
Using broad race/ethnic categories can obscure differences between subgroups [32], and federal data
collection standards for race categories have been found to mask heterogeneity in smoking patterns [33].
Although Asians are the fastest growing race/ethnic group in the U.S. [34], studies of smoking patterns
have categorized Asian/Pacific Islander as a single group or more typically been limited to white,
African-American and sometimes Hispanic groups. Even less is known about racial/ethnic variability in
ETS exposure, which may not follow patterns for active smoking due to gender and cultural differences
in active smoking [35]. Accurate understanding of race/ethnic tobacco exposure rates is further
complicated by differences in women’s non-disclosure patterns by race/ethnicity [27], and patterns of
quitting smoking during pregnancy, which also vary by race/ethnic group [3].
Using cotinine measurements from prenatal serum and associated demographic data, our aim
was to describe active smoking and ETS exposure during pregnancy by race/ethnicity in a multi-ethnic
population. Subjects from a population-based cohort of pregnant women in Southern California
in 1999–2002 were selected to represent 13 racially/ethnically diverse populations: white, African
American, Hispanic, Native American, and nine understudied Asian/Pacific Islander subgroups:
Chinese, Japanese, Korean, Filipino, Cambodian, Vietnamese, Laotian, Samoan, and Asian Indian.
We describe race/ethnic tobacco exposure patterns among these diverse groups, providing a baseline
for future work to assess secular changes in exposure patterns and association with long-term disease
outcomes. We chose the major nicotine metabolite, cotinine, as a biomarker and a highly sensitive
laboratory method in order to obtain an objective measure of exposure from active smoking and ETS
exposure within these different groups.
2. Materials and Methods
2.1. Study Population
We sampled pregnant women from San Diego, Orange, and Imperial counties who participated in
California’s statewide prenatal screening program between November 1999 and December 2002. During
this period, California offered prenatal screening to pregnant women in mid-pregnancy to detect several
chromosomal and other congenital disorders [36]. Typically, a single blood specimen was collected from
the enrollee between 15 and 20 weeks of pregnancy, and banked as part of Project Baby’s Breath (PBB),
a population-based research study in the 2000s established by several investigators of the present study
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(Kharrazi, DeLorenze and Pearl) [37]. PBB created a biological specimen bank and database based on
probabilistically-linked birth certificate, prenatal screening and other records. It was designed to enable
cross-sectional and longitudinal investigations concerning environmental exposures and periconception,
pregnancy, and subsequent health outcomes. Funding for cotinine analysis of race/ethnicity subgroups
within PBB was obtained in 2005. From the 191,441 prenatal screening records corresponding to banked
PBB prenatal specimens, 300 subjects (except where noted) were randomly selected, from each of the
following Asian/Pacific Islander race/ethnic groups: Asian Indian, Cambodian, Chinese, Filipino,
Japanese, Laotian, Korean, Samoan (N = 184), and Vietnamese. Subjects from four other race/ethnic
groups with available specimens were also included: Hispanic (N = 97), white (N = 103) and African
American (N = 300) and Native American (N = 245); (total N with specimens = 3329). Demographic
variables other than race/ethnicity were based on linked birth record data (mother’s age; years of
education; public versus private payment source for birth or delivery services; and foreign- versus
U.S.-born status). Of the 3329 records with specimens, 3054 linked with birth record data, and another
40 had missing values for one or more demographic characteristics, resulting in 3014 subjects with
complete data (both serum cotinine measurements and demographic data).
Screening program enrollees signed consent forms allowing for research and confidential use
of program data and specimens by the State of California or State-approved scientific researchers
without identifying the person or persons from whom these results were obtained, unless an enrollee
specifically prohibited such use in writing. Women who requested that their specimens not be used
for research, which was rare, were not included in the study. Approval for the research project was
obtained from the California Health and Human Services Agency Committee for the Protection of
Human Subjects in 2003 (#13-02-1072).
2.2. Laboratory Cotinine Analysis
PBB contracted with the regional newborn and prenatal screening laboratory serving San
Diego, Orange, and Imperial counties during November 1999 to December 2002 to bank blood
specimens. Initially, serum specimens were retained in original serum separator tubes at −20 ◦C with
accompanying blood cell pellets. Between June 2000 and December 2002, serum was aliquotted
at the regional laboratory within 1–2 days of testing into a single 4 mL sterile polypropylene
non-pyrogenic, cryogenic vial and stored at −20 ◦C. Serum cotinine levels were measured by the
Wadsworth Center, Division of Environmental Disease Prevention, New York State Department of
Health, from November 2007 to June 2008 using a highly sensitive isotope dilution high performance
liquid chromatography/tandem mass spectrometry (LC/MS/MS) method. The analysis was a
modification of techniques used by the Centers for Disease Control and Prevention [38]. A small
subset (N = 27 Hispanic and N = 34 white) were analyzed for cotinine using the same liquid
chromatographic-atmospheric pressure chemical ionization tandem mass spectrometry method by the
Tobacco Exposure Biomarkers Section, Division of Laboratory Sciences, Centers for Disease Control
and Prevention in 2006. For validation purposes, a subset of serum specimens from PBB were tested by
both laboratories (N = 28). Correlation between the two laboratory values, calculated as raw cotinine
minus overall average of study blanks, was 0.99. The method had a quantitation limit of 0.025 ng/mL
and a limit of detection of 0.001 ng/mL.
2.3. Data Analysis
Demographic and socioeconomic characteristics were examined by race/ethnicity among records
with complete data (N = 3104). In the total population (N = 3329), prevalence of active smoking
among the different race/ethnic groups was assessed based on measured serum cotinine cutpoints as
recommended by Benowitz et al. [39] as follows: For adults (age > 19 years), 5 ng/mL for non-Hispanic
whites, 6 ng/mL for non-Hispanic blacks, and 1 ng/mL for Mexican-Americans; for adolescents (age
12–19 years), 3 ng/mL for non-Hispanic whites and blacks, and 1 ng/mL for Mexican-Americans.
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The recommended cutpoint of 3 ng/mL for the overall U.S. population was used for subjects not
falling in the above categories.
Women with serum cotinine values below these cutpoints were designated as nonsmokers in
their respective age/race/ethnic groups (N = 3180). All serum cotinine values in ng/mL were initially
rounded to three decimal places, and values below the detection limit (0.001 ng/mL) were included
after assigning the value of 0.001/
√
2. We used values below the quantitation limit (0.025 ng/mL)
and above the detection limit to most closely estimate the lognormal distribution of exposure in study
subjects. Prevalence of detectable ETS exposure among non-smokers was assessed (serum cotinine >
0.001 and less than the designated cutpoint) for each race/ethnic group, as well as the distribution of
and geometric means of cotinine values (with 95% confidence intervals) and interquartile ranges. Tests
to determine differences in mean log10 serum cotinine between race/ethnic groups were performed
using the SAS ANOVA procedure and the Least Significant Difference (LSD) approach to account for
multiple comparisons (SAS Statistical Software, v9.4, SAS Institute, Cary, NC, USA).
Among non-smokers, multivariable linear regression of log serum cotinine was used to evaluate
whether the crude relationships between race/ethnicity were due to other demographic factors. Age
was modeled as a continuous and a quadratic term, while education (less than 16 years versus more)
and insurance (publicly funded/indigent versus private) were modeled as dichotomous covariates.
Indicator variables were included for each race/ethnic group (except white women) in order to compare
mean log cotinine for each group relative to white women after adjusting for other demographic factors.
Race/ethnicity and other demographic variables were evaluated both individually and as groups
of variables.
3. Results
All demographic characteristics evaluated varied widely by race/ethnicity (Table 1, dataset with
complete demographic values, N = 3014). For example, 4.4% of mothers of Chinese background were
age 25 or younger; and at the other end of the spectrum, 47.5% of African American mothers fell in
this age category. The percent of Chinese mothers with less than 16 years of education was 20.4%,
compared to 91.8% of Samoans. Chinese mothers had the lowest percent of public funding (3.3%),
followed by Japanese (7.2%); with Hispanic mothers at 62.2%. The group with the highest percent of
foreign-born mothers were Vietnamese (98.6%); the Asian/Pacific Islander subgroup with the lowest
percentage of foreign-born mothers was Samoan (42.4%).
Table 1. Demographic characteristics of prenatal screening program enrollees in 13 race/ethnic groups,
San Diego, Orange and Imperial counties (N = 3014) *.
Race/Ethnicity N = 3014 Column %
Mother’s
Age≤ 25
Years (%)
Mother’s
Education <
16 Years (%)
Mother’s
Insurance Public
Funding (%)
Mother is
Foreign-Born
(%)
White 95 3.2 20.0 49.5 14.7 13.7
African American 263 8.7 47.5 87.5 57.0 8.7
Hispanic 82 2.7 37.8 89.0 62.2 70.7
Asian Indian 274 9.1 11.3 29.2 11.3 91.6
Cambodian 274 9.1 43.1 82.8 41.2 90.9
Chinese 275 9.1 4.4 20.4 3.3 88.7
Filipino 274 9.1 17.9 51.8 14.2 76.6
Japanese 265 8.8 5.7 42.6 7.2 65.3
Korean 262 8.7 6.1 29.8 17.2 94.3
Laotian 280 9.3 32.9 81.1 32.9 90.4
Native American 213 7.1 40.4 85.9 33.8 8.0
Samoan 170 5.6 41.8 91.8 42.9 42.4
Vietnamese 287 9.5 13.2 74.9 31.4 98.6
Chi Square p-value <0.0001 <0.0001 <0.0001 <0.0001
* Of 3329 total records with serum cotinine specimens, 3014 linked with birth records and had complete data for
demographic variables.
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Prevalence of active smoking, as determined by measured cotinine levels, varied between 0.3
and 14.1% (Table 2; dataset with specimens, N = 3329). The race/ethnic groups with the highest
percentages of active smokers (in decreasing order) were Samoan, African American, Native American
and white (6.8–14.1%). Although numbers were small and thus statistical distinctions between groups
uncertain, Korean, Cambodian, Hispanic, Japanese and Laotian race/ethnic groups appeared to have
intermediate levels of active smoking (2.0–4.0% prevalence), and the groups with the lowest prevalence
included women of Filipino, Chinese, Vietnamese and Asian Indian background (0.3–1.0%).
Table 2. Smoking prevalence (95% confidence interval) during mid-pregnancy for prenatal screening
program enrollees in 13 race/ethnicity groups; San Diego, Orange and Imperial counties; by descending
prevalence (N = 3329).
Race-Ethnicity No No of Smokers * % 95% Confidence Interval
Samoan 184 26 14.1 9.8–19.9
African American 300 38 12.7 9.4–16.9
Native American 245 31 12.7 9.1–17.4
White 103 7 6.8 3.3–13.4
Korean 300 12 4.0 2.3–6.9
Cambodian 300 10 3.3 1.8–6.0
Hispanic 97 3 3.1 1.1–8.7
Japanese 300 7 2.3 1.1–4.7
Laotian 300 6 2.0 0.9–4.3
Filipino 300 3 1.0 0.3–2.9
Chinese 300 3 1.0 0.3–2.9
Vietnamese 300 2 0.7 0.2–2.4
Asian Indian 300 1 0.3 0.1–1.9
* Smoking status defined by race- and age-specific cutpoints per Benowitz et al. 2008 [39].
Of our total population of 3329 with measured cotinine levels, we identified 3180 women
as non-smoking. Prevalence of ETS exposure as measured by geometric mean cotinine among
non-smoking women was highest among the following groups: African Americans and Samoans,
followed by Cambodians, Native American, Vietnamese and Koreans (Table 3). The groups with the
lowest prevalence of ETS exposure were Filipino, Japanese, white, and Chinese. These race/ethnic
rankings tracked similarly with percent of detectable cotinine, and the vast majority of women had
detectable cotinine levels (75.0–90.5%).
Comparison of active smoking and ETS exposure patterns are visualized in Figure 1, which
shows prevalence of active smoking for each race/ethnic group along with each group’s geometric
mean cotinine level among non-smokers. While consistent patterns were apparent for many groups,
e.g., high active smoking prevalence and high ETS exposure among non-smokers, divergent patterns
were suggested in other groups. The upper right quadrant represents race/ethnic groups with both
high active smoking and high ETS exposure (African Americans, Samoans, and Native Americans).
However, while smoking prevalence among white women was relatively high among these race/ethnic
groups, the average level of ETS exposure was low among non-smoking white women (upper left
quadrant). While prevalence of active smoking among Vietnamese women was low, their ETS exposure
was relatively high. Cambodians and Koreans also fell in this quadrant, but most Asian groups
clustered in the lower left quadrant, suggesting low levels of both active smoking and ETS exposure.
Samoans were an exception, standing out from other Asian/Pacific Islander groups with both high
levels of active smoking and ETS exposure, similar to Native Americans and African Americans.
Hispanics appeared to have more similar smoking patterns to the Asian groups in the lower left
quadrant, characterized by low active smoking and low/intermediate ETS exposure.
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Table 3. Comparisons of mid-pregnancy serum cotinine levels between 13 race/ethnic groups of
non-smoking * prenatal screening program enrollees; mean geometric serum cotinine levels with 95%
confidence intervals; percent detectable serum cotinine; and interquartile ranges; San Diego, Orange
and Imperial counties (N = 3180).
Race-Ethnicity † N
% Detectable
Cotinine
Geometric Mean
Cotinine (ng/mL) ‡
95% Confidence
Interval
IQR 25–75th
Percentile
African American a 262 90.5 0.034 0.026–0.044 0.009–0.151
Samoan a,b 158 88.0 0.025 0.018–0.034 0.010–0.077
Cambodian b,c 290 90.3 0.020 0.016–0.025 0.006–0.066
Native American c 214 84.6 0.017 0.013–0.022 0.004–0.058
Vietnamese c 298 90.3 0.017 0.014–0.020 0.006–0.046
Korean c,d 288 88.2 0.015 0.012–0.018 0.006–0.039
Laotian d,e 294 80.6 0.011 0.009–0.014 0.003–0.039
Asian Indian e,f 299 82.3 0.009 0.008–0.011 0.003–0.030
Hispanic e,f,g 94 79.8 0.009 0.006–0.012 0.003–0.028
Filipino f,g 297 75.1 0.007 0.006–0.009 0.001–0.030
Japanese f,g,h 293 75.4 0.007 0.005–0.008 0.001–0.020
White g,h 96 75.0 0.006 0.004–0.009 0.001–0.019
Chinese h 297 75.4 0.005 0.004–0.006 0.001–0.017
* Non-smoking status defined by race- and age-specific cutpoints per Benowitz et al. 2008 [39]. † Lettered
superscripts indicate no statistically significant differences between race/ethnic groups in geometric mean serum
cotinine levels (p < 0.05). For example, no distinction can be made between African Americans and Samoans as
to which group had higher environmental tobacco smoke (ETS) exposure, and African Americans had higher
ETS exposure than any other race/ethnic group other than possibly Samoans. ‡ By descending geometric mean
cotinine level.
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(N = 3180); prenatal screening program enrollees in 13 race/ethnic groups; San Diego, Orange and 
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Figure 1. Percent active smokers (N = 3329); vs geometric mean serum cotinine levels in non-smokers
(N = 3180); prenatal screening program enrollees in 13 race/ethnic groups; San Diego, Orange and
Imperial counties. (Smoking status defined by race- and age-specific cutpoints per Benowitz et al.
2008 [39]. Grid lines show the mean of percent active smokers in the 13 race/ethnic groups and the
antilog of the mean log cotinine in non-smokers in the 13 groups.)
Race/ethnicity, as a group including all race/ethnic subtypes, was strongly associated with
serum cotinine level (log10 serum cotinine, ng/mL) in multivariable regression among non-smokers
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(p < 0.001) (Table 4). Using both linear and quadratic age variables in the model improved the fit over
using the linear term alone, based on Akaike Information Criterion (AIC) values, so both terms were
included in the final model. All demographic variables (excluding race/ethnicity), separately and as a
group, were also significantly associated with cotinine concentration (p ≤ 0.001, grouped demographic
variables). After adjusting for these variables, race/ethnic differences persisted although there was
some shifting of ETS rankings compared to unadjusted results in Table 3, with Koreans ranking highest
and Hispanics lowest. Being born outside the U.S. was associated with lower cotinine, but was not
significantly associated with cotinine concentration in multivariate models with demographic and
race/ethnicity variables and so was not retained in the final model (data not shown).
Table 4. Regression analysis of race/ethnicity and other demographic characteristics and environmental
tobacco smoke (ETS) exposure (log10 serum cotinine, ng/mL) among non-smoking * prenatal screening
program enrollees; San Diego, Orange and Imperial counties (N = 2880) †.
Variable Parameter Estimate (log10 Cotinine, ng/mL) ‡ Pr > F
Model R2 = 0.18
Intercept −0.687 0.044
Demographic covariates (as group) <0.0001
Mother has less than 16 years of education 0.233 <0.0001
Mother’s care is publicly funded 0.346 <0.0001
Mother’s age (continuous) −0.098 <0.0001
Mother’s age (squared term) 0.001 0.001
Race/ethnic covariates * (as group) <0.0001
Korean 0.429 <0.0001
African-American 0.403 <0.0001
Samoan 0.367 <0.0002
Vietnamese 0.319 0.0004
Cambodian 0.269 0.0030
Native American 0.228 0.0165
Asian Indian 0.223 0.0125
Japanese 0.120 0.1825
Laotian 0.108 0.2298
Chinese 0.084 0.3472
Filipino 0.050 0.5727
Hispanic −0.207 0.0716
* Non-smoking status defined by race- and age-specific cutpoints per Benowitz et al. 2008 [39]. † Subjects with
complete demographic data. ‡ Difference in mean log10 cotinine concentrations for each race/ethnic group, white
as reference; race/ethnic groups displayed in descending order of magnitude of parameter estimate.
4. Discussion
Using serum cotinine as an objective biomarker for tobacco smoke exposure over the previous
few days in mid-pregnancy, our study identified significantly different exposure prevalence for active
smoking and ETS exposure among 13 different race/ethnic populations, suggesting that lifestyle
and social patterns associated with tobacco exposure differ between groups. Among non-smokers,
most pregnant women were exposed to ETS. As expected, socioeconomic factors and maternal age
were clearly important predictors of ETS exposure. Race/ethnicity remained strongly associated even
after these adjustments. Based on the unadjusted results, which inform public health practice, the
subpopulations with high active smoking and ETS exposure included African American, Samoan
and Native American women. ETS exposure was also elevated among Cambodians, Vietnamese
and Koreans, and lowest among Chinese, white, Japanese, Filipino, Hispanic, and Asian Indian
women. Active smoking and ETS exposure patterns did not always track together across groups; for
example, white women had high active smoking and low ETS exposure, while Korean, Cambodian
and Vietnamese women had moderate to low active smoke exposure, but high ETS exposure.
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The varying rates of active smoking and ETS exposure across race/ethnic groups may relate
to many factors, including language barriers, lack of insurance, barriers to participation in smoking
cessation programs and other cultural and socioeconomic factors. The discordant active smoking and
ETS exposure patterns between different race/ethnic groups seen in Figure 1 may be a reflection of
gender differences in tobacco use or social stratification. Smoking behavior is a cultural norm in some
communities, such as among men in Southeast Asian countries, and smoking prevalence remains high
among males in those race/ethnic groups in the U.S. [40]. A study of non-smoking Vietnamese adults
in California found high secondhand exposure in home environments for women [41]. Social dynamics
may play a role; a study of family communication in Vietnamese and Chinese families identified a
pattern of “suffering in silence [42].” In a study of Asian/Pacific Islanders in Hawaii, native Hawaiians
with large social networks were found to have lower smoking rates, but this was not so for Filipinos or
East Asians [43]. The East Asian category, however, was comprised of Chinese, Japanese and Koreans.
In our analysis, pregnant nonsmokers who were Chinese had relatively low exposure to ETS, but
Koreans were among the groups with higher ETS exposure.
Race/ethnic factors beyond family and social dynamics may affect smoking patterns as well,
such as the context of residential enclaves and segregation. Living in a Mexican residential enclave is
associated with decreased smoking during pregnancy for mothers of Mexican origin, while living in a
non-Hispanic white neighborhood was associated with increased smoking [44]. Residence in a less
racially segregated area has been related to a lower risk of smoking during pregnancy among African
American women, but higher smoking risk among Asian and Hispanic women [45]. African-Americans
and other minorities may also encounter more tobacco advertising and greater access to tobacco
products in their communities [46,47].
In addition to race/ethnic differences in smoking rates, cessation-related knowledge and practices
may differ as well. Native Hawaiians and Filipinos were found in a previous study to have lower
knowledge and use of cessation methods and products than Caucasians, suggesting that these groups
may be underserved [48]. Tobacco companies have specifically targeted Asian immigrants and
Asian Americans [49], while few interventions have been directed towards these communities [32].
To address this gap, the Centers for Disease Control and Prevention’s “Racial and Ethnic Approaches
to Community Health” (REACH) project was launched to reduce racial/ethnic community health
disparities using community-driven anti-smoking strategies [40]. Knowledge of differences in smoking
patterns for specific ethnic groups is critical, as culturally appropriate interventions have been found
to be more effective [32,50–52].
Tobacco control policies have been demonstrated to reduce prenatal smoking rates [53–55].
Decreases in adverse maternal and child outcomes have also been demonstrated to be affected by
tobacco control policies [56,57]. The introduction of increased cigarette taxes and marketing bans
have shown a 5–10% reduction in adverse maternal and child outcomes [53]. The effectiveness of
tobacco control policies may also vary by race/ethnic group, possibly modified by socioeconomic
status. A study of the impact of increased cigarette taxes found that smoking rates were most improved
among white and African American mothers with the least education [55]. However, investigators also
found that increased taxes were associated with a slight increase in the number of cigarettes smoked
per month among Hispanic mothers without a high school degree and Asians with a college degree
or higher.
Pregnant women represent a key nexus in the effort to control the nation’s tobacco exposure.
From the direct effects on the fetus that may manifest in poor birth outcomes, to those that develop in
childhood and later in the lifespan, to parental smoking and the child’s ETS exposure, and continuing
to intergenerational and epigenetic effects on descendants, pregnancy presents an opportunity to
intervene in the trajectory of the most significant preventable cause of death and disease in the U.S.
Strategies are needed that acknowledge the role of both parents and family members or others living
in the home. Also of critical importance is addressing the upcoming generation of future mothers
and fathers who are currently children and adolescents in order to interrupt smoking initiation and
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lifelong addiction. Unfortunately, progress in reducing tobacco exposure has been hindered by rising
e-cigarette use, which has tripled among high school and middle school children between 2013 and
2014, surpassing traditional cigarette use for the first time, according to the National Youth Tobacco
Survey [58].
To our knowledge, this is the first study to biochemically quantify exposure to tobacco in this
variety of ethnic subgroups, particularly for Asian/Pacific Islander subpopulations. The study is
population-based, deriving from all prenatal screening program participants in the southern part of
the state. The cotinine assay is the most sensitive available, allowing quantification at low levels of
ETS. The period of study, 1999–2002, predated the introduction of e-cigarettes, so the serum cotinine
levels measured here were largely through exposure to nicotine in tobacco smoke.
The study has several limitations. Despite our efforts to sample understudied race/ethnic
populations, subject numbers were smaller than ideal, especially for analysis of populations with lower
prevalence of active smoking. However, our ETS analyses are more robust. Given that the half-life of
cotinine is shorter in pregnancy (around 9 h versus 17 h in non-pregnant [59]), and the use of a single
specimen to measure serum cotinine in this study, there is opportunity to misclassify true smokers as
non-smokers, especially light or intermittent smokers, or women who quit before the second trimester.
This same problem could raise cotinine levels in non-smoker groups, but given use of the geometric
mean, a measure of the central tendency for a log normal distribution, this metric should be minimally
impacted. Although we used the most valid cutpoints as based on race and age-specific values and
appropriate to the time period of our study, these values were only available for three race/ethnic
groups. However, a sensitivity analysis using a serum cotinine cutpoint of 10 ng/mL to define smoking
for all race/ethnic groups did not reveal any material differences in the results presented. No cutpoints
have been defined specifically for pregnant women, despite differences in metabolism that could affect
their cotinine levels [59]. Additionally, the timing of the prenatal screening, which occurs between
15 and 20 weeks of pregnancy, may not reflect exposure during other critical exposure windows of
time and could miss women who had smoked but had quit earlier in pregnancy. The study will also
miss women who do not participate in prenatal screening. Previous research has found that women
under 20 or over 35 years of age, with late or no prenatal care, or public insurance, are less likely to
participate in prenatal screening [60], although it is uncertain how these selection factors may influence
the distribution of active smoking and ETS exposure. It is possible that the tobacco exposure patterns
we identified were influenced by factors beyond those considered in this examination, including
potential differences across the groups in use of certain medications, alcohol consumption, and genetic
factors affecting the metabolism of nicotine and cotinine [61]. It is unknown whether the combination
of these unmeasured factors would change the conclusions of this paper.
5. Conclusions
Substantial variability in patterns of active smoking and ETS exposure during pregnancy was
revealed among the 13 race/ethnic groups in the present study. Prevalence of active smoking was
highest among African American, Samoan, Native American and white women, and lowest among
Asian Indians, Vietnamese, Chinese, and Filipinos. Among non-smokers, ETS exposure was highest
among African Americans and Samoans, followed by Cambodians, Native Americans, Vietnamese
and Koreans, and lowest among Filipino, Japanese, white, and Chinese women. While high active
smoking was often accompanied by high ETS exposures, discordant patterns included white women
with relatively high rates of active smoking, but low ETS exposure among non-smokers, and relatively
high ETS exposure among Vietnamese women although they rarely smoked.
While cultural differences may likely have persisted since the early 2000s when this study’s blood
specimens were collected, follow-up surveillance that distinguishes specific subgroups is needed
to assess current exposure levels. These historical exposure differences may lead to subsequent
differences in pediatric outcomes and even beyond into adulthood. Comprehensive tobacco control
and prevention programs have been effective in reducing tobacco use in the U.S., and in particular in
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California [62,63]. However, the disparities in active tobacco use and ETS exposure among race/ethnic
groups underscore the importance of culturally and ethnically relevant interventions and surveillance,
including verification based on biospecimen testing for accuracy, in order to advance progress towards
the goal of reducing tobacco’s harm.
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